Loading company…
Loading company…
CRL · Health Care
Charles River Laboratories's distance from the ideal is driven mostly by Asset turnover and FCF margin. It sits closest to the frontier on Controversy level.
Laggard · bottom 20% of Health Care · score 40.3 · rank 57/59
| Purchased electricity | n/a |
| On-site fuel combustion | n/a |
| Vehicle fleets | n/a |
| Process emissions | n/a |
| Fugitive emissions | n/a |
Benchmark: burden 0.00 years of earnings (sector median 0.00 years), fossil revenue 0%, beneficiary revenue 0%, net debt/EBITDA 11.0x; largest gaps to the sector ideal: leverage vs sector target and transition burden.